The U.S. Food and Drug Administration (FDA) has a black-box warning for Veozah, the first hormone-free medication for hot ...

The FDA has placed its most serious warning - called a Boxed Warning - on the non-hormonal drug fezolinetant, which is sold ...

Liver cirrhosis is a serious condition where healthy liver tissue is replaced with scar tissue, making it harder for the ...

The US Food and Drug Administration has placed its most serious warning — a so-called black-box warning — on a drug used to ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects around 30% of the global population. Studies suggest ...

Liver elastography confirms liver fibrosis (stiffness) and helps providers reach a diagnosis to suggest treatment. Learn ...

An estimated 100 million Americans have some form of liver disease, yet only 4.5 million U.S. adults have received a formal ...

New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye disease.

Following a review of postmarket clinical trial data, the FDA identified several cases of serious liver injury among patients using Ocaliva, with some requiring liver transplants, according to a Dec.

The EMA’s Committee for Medicinal Products for Human Use (CHMP) determined that expected clinical benefits of seladelpar include delayed development of liver fibrosis and cirrhosis, potentially ...

A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks.